It has been shown that sulforaphane, a potent agonist of Nrf2, ameliorated depression-like behavior in LPS-induced mice, decreased serum levels of TNF-α and IL-10, and inhibited activation of microglia. The gene discussed is TNF; the disease is depressive symptom measurement.